Details for 2023178015
Up to date per 05.04.2026
Actions
Details for 2023178015
Granted/Registered
European Patent
23.08.2023 A
28.01.2026 B1
14.03.2013
US
201361782445 P
31.01.2014
US
201461934365 P
C07C 219/08 20060101AFI20240130BHEP
Owner
Alkermes Pharma Ireland LimitedConnaught House 1 Burlington Road Dublin 4IE
Representative
No representatives present
Inventor
ZEIDAN, Tarek A. Lexington, MA 02420US
DUNCAN, Scott Bedford, MA 01730US
HENCKEN, Christopher P. Boston, MA 02132US
WYNN, Thomas Andrew Lexington, MA 02420US
SANRAME, Carlos N. Lexington, MA 02420US
Information about Fees